NCT07648277

Brief Summary

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system characterized by demyelination and axonal degeneration. Neuromuscular impairments associated with MS, including muscle weakness, spasticity, fatigue, and proprioceptive deficits, may lead to alterations in spinal posture and reduced spinal mobility. These changes can negatively affect trunk control, balance, respiratory function, and functional independence. Although postural abnormalities and mobility limitations have been reported in individuals with MS, the relationship between spinal posture, spinal mobility, and balance remains insufficiently investigated. Therefore, this study aims to examine the associations between spinal posture, spinal mobility, and balance performance in individuals with multiple sclerosis. Improved understanding of these relationships may contribute to the development of targeted rehabilitation interventions aimed at enhancing postural control and functional outcomes in this population. This study further hypothesises that alterations in spinal posture and spinal mobility are associated with impaired balance performance in individuals with multiple sclerosis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
1mo left

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Feb 2026Jun 2026

Study Start

First participant enrolled

February 1, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 10, 2026

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 15, 2026

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

June 15, 2026

Status Verified

June 1, 2026

Enrollment Period

4 months

First QC Date

June 10, 2026

Last Update Submit

June 10, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Spinal alignment

    Spinal alignment was assessed in the sagittal and frontal planes during neutral standing, maximal trunk flexion, and maximal trunk extension. All spinal alignment parameters were recorded as angular values and expressed in degrees (°).

    1 hour

  • Spinal mobility

    Spinal mobility was assessed in both the sagittal and frontal planes. In the sagittal plane, mobility was calculated as the angular difference between the neutral standing posture and maximal trunk flexion and extension positions. In the frontal plane, lateral flexion mobility was calculated as the angular difference between the neutral standing posture and maximal right and left lateral flexion positions. All measurements were recorded in degrees (°).

    1 hour

Secondary Outcomes (2)

  • Single-Leg Stance

    1 hour

  • Time Up and Go

    1 hour

Study Arms (1)

Multiple Sclerosis

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Neurologist-confirmed diagnosis of relapsing-remitting multiple sclerosis (RRMS)

You may qualify if:

  • Diagnosis of relapsing-remitting multiple sclerosis (RRMS)
  • Aged between 18 and 65 years
  • EDSS score between 0.5 and 4.5
  • Standardized Mini-Mental State Examination score ≥24

You may not qualify if:

  • Receipt of corticosteroid treatment within the previous 4 weeks
  • Presence of any additional neurological disorder
  • Spasticity defined as a Modified Ashworth Scale score ≥3
  • History of surgical intervention involving the lower extremities, spine, or abdominal region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Yıldırım Beyazıt University

Ankara, Çubuk, 06760, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2026

First Posted

June 15, 2026

Study Start

February 1, 2026

Primary Completion

June 12, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

June 15, 2026

Record last verified: 2026-06

Locations